Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Biological activities of Ficus carica latex for potential therapeutics in Human Papillomavirus (HPV) related cervical cancers.

Ghanbari A, Le Gresley A, Naughton D, Kuhnert N, Sirbu D, Ashrafi GH.

Sci Rep. 2019 Jan 31;9(1):1013. doi: 10.1038/s41598-018-37665-6.

2.

DNA methyltransferases and gastric cancer: insight into targeted therapy.

Fattahi S, Golpour M, Amjadi-Moheb F, Sharifi-Pasandi M, Khodadadi P, Pilehchian-Langroudi M, Ashrafi GH, Akhavan-Niaki H.

Epigenomics. 2018 Nov;10(11):1477-1497. doi: 10.2217/epi-2018-0096. Epub 2018 Oct 16. Review.

PMID:
30325215
3.

Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines.

Stanley A, Ashrafi GH, Seddon AM, Modjtahedi H.

Sci Rep. 2017 Jun 21;7(1):3964. doi: 10.1038/s41598-017-04301-8.

4.

Association of High Risk Human Papillomavirus and Breast cancer: A UK based Study.

Salman NA, Davies G, Majidy F, Shakir F, Akinrinade H, Perumal D, Ashrafi GH.

Sci Rep. 2017 Feb 27;7:43591. doi: 10.1038/srep43591.

5.

A systematic review and meta-analysis of seroprevalence of varicella zoster virus: A nationwide population-based study.

Amjadi O, Rafiei A, Haghshenas M, Navaei RA, Valadan R, Hosseini-Khah Z, Omran AH, Arabi M, Shakib RJ, Mousavi T, Ashrafi GH.

J Clin Virol. 2017 Feb;87:49-59. doi: 10.1016/j.jcv.2016.12.001. Epub 2016 Dec 6. Review.

PMID:
28011413
6.

Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study.

Haghshenas M, Golini-Moghaddam T, Rafiei A, Emadeian O, Shykhpour A, Ashrafi GH.

Infect Agent Cancer. 2013 Jun 6;8(1):20. doi: 10.1186/1750-9378-8-20.

7.

Varicella-zoster viruses associated with post-herpetic neuralgia induce sodium current density increases in the ND7-23 Nav-1.8 neuroblastoma cell line.

Kennedy PG, Montague P, Scott F, Grinfeld E, Ashrafi GH, Breuer J, Rowan EG.

PLoS One. 2013;8(1):e51570. doi: 10.1371/journal.pone.0051570. Epub 2013 Jan 31.

8.

Genome-wide expression profiling of urinary bladder implicates desmosomal and cytoskeletal dysregulation in the bladder exstrophy-epispadias complex.

Qi L, Chen K, Hur DJ, Yagnik G, Lakshmanan Y, Kotch LE, Ashrafi GH, Martinez-Murillo F, Kowalski J, Naydenov C, Wittler L, Gearhart JP, Draaken M, Reutter H, Ludwig M, Boyadjiev SA.

Int J Mol Med. 2011 Jun;27(6):755-65. doi: 10.3892/ijmm.2011.654. Epub 2011 Mar 22.

PMID:
21431277
9.

HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells.

Campo MS, Graham SV, Cortese MS, Ashrafi GH, Araibi EH, Dornan ES, Miners K, Nunes C, Man S.

Virology. 2010 Nov 10;407(1):137-42. doi: 10.1016/j.virol.2010.07.044.

10.

Assessment of transcriptomal analysis of Varicella-Zoster-virus gene expression in patients with and without post-herpetic neuralgia.

Ashrafi GH, Grinfeld E, Montague P, Forster T, Ross A, Ghazal P, Scott F, Breuer J, Goodwin R, Kennedy PG.

Virus Genes. 2010 Oct;41(2):192-201. doi: 10.1007/s11262-010-0515-2. Epub 2010 Jul 23.

PMID:
20652732
12.

Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain.

Barbaresi S, Cortese MS, Quinn J, Ashrafi GH, Graham SV, Campo MS.

J Gen Virol. 2010 Feb;91(Pt 2):521-30. doi: 10.1099/vir.0.016295-0. Epub 2009 Oct 7.

PMID:
19812262
13.

Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1.

Ashrafi GH, Piuko K, Burden F, Yuan Z, Gault EA, Müller M, Trawford A, Reid SW, Nasir L, Campo MS.

J Gen Virol. 2008 Jan;89(Pt 1):148-57.

PMID:
18089738
14.
15.

The E5 oncoprotein of BPV-4 does not interfere with the biosynthetic pathway of non-classical MHC class I.

Araibi EH, Marchetti B, Dornan ES, Ashrafi GH, Dobromylskyj M, Ellis SA, Campo MS.

Virology. 2006 Sep 15;353(1):174-83. Epub 2006 Jun 27.

16.

Down-regulation of MHC class I is a property common to papillomavirus E5 proteins.

Ashrafi GH, Brown DR, Fife KH, Campo MS.

Virus Res. 2006 Sep;120(1-2):208-11. Epub 2006 Jun 15.

PMID:
16780984
17.

Three rare cases of anthrax arising from the same source.

Babamahmoodi F, Aghabarari F, Arjmand A, Ashrafi GH.

J Infect. 2006 Oct;53(4):e175-9. Epub 2006 Jan 25.

PMID:
16442628
18.

The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus.

Marchetti B, Ashrafi GH, Dornan ES, Araibi EH, Ellis SA, Campo MS.

Oncogene. 2006 Apr 6;25(15):2254-63.

PMID:
16288210
19.

Similarities and differences between the E5 oncoproteins of bovine papillomaviruses type 1 and type 4: cytoskeleton, motility and invasiveness in E5-transformed bovine and mouse cells.

Tsirimonaki E, Ullah R, Marchetti B, Ashrafi GH, McGarry L, Ozanne B, Campo MS.

Virus Res. 2006 Feb;115(2):158-68. Epub 2005 Sep 15.

PMID:
16168512
20.

Clinical and molecular characterization of the bladder exstrophy-epispadias complex: analysis of 232 families.

Boyadjiev SA, Dodson JL, Radford CL, Ashrafi GH, Beaty TH, Mathews RI, Broman KW, Gearhart JP.

BJU Int. 2004 Dec;94(9):1337-43.

21.

Downregulation of major histocompatibility complex class I in bovine papillomas.

Araibi EH, Marchetti B, Ashrafi GH, Campo MS.

J Gen Virol. 2004 Oct;85(Pt 10):2809-14.

PMID:
15448341
22.

E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I.

Ashrafi GH, Haghshenas MR, Marchetti B, O'Brien PM, Campo MS.

Int J Cancer. 2005 Jan 10;113(2):276-83.

23.
24.

Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins.

Ashrafi GH, Tsirimonaki E, Marchetti B, O'Brien PM, Sibbet GJ, Andrew L, Campo MS.

Oncogene. 2002 Jan 10;21(2):248-59.

25.
26.

A mutational analysis of the transforming functions of the E8 protein of bovine papillomavirus type 4.

O'Brien V, Ashrafi GH, Grindlay GJ, Anderson R, Campo MS.

Virology. 1999 Mar 15;255(2):385-94.

27.

Supplemental Content

Loading ...
Support Center